Release Date: 11/03/09 09:55 Summary: Change in substantial holding from SAI Price Sensitive: No Download Document 89.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%